Highland Capital Management (Texas)’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Highland Capital Management (Texas)’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-21,891	Closed	-$3.42M	–	258
2014 Q4	$3.42M	Buy	21,891 +4,146	+23%	+$766K	0.11%	117
2014 Q3	$4.2M	Buy	17,745 +11,369	+178%	+$2.9M	0.16%	118
2014 Q2	$1.51M	Buy	6,376 +2,166	+51%	+$571K	0.06%	149
2014 Q1	$1.39M	Sell	4,210 -16,426	-80%	-$5.54M	0.06%	143
2013 Q4	$1.41M	Sell	20,636 -8,315	-29%	-$481K	0.08%	93
2013 Q3	$2M	Sell	28,951 -21,349	-42%	-$1.05M	0.13%	82
2013 Q2	$2.25M	Buy	+50,300	New	+$1.72M	0.17%	76

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Highland Capital Management (Texas)'s ICPT Position: Q1 2015 in Review

Highland Capital Management (Texas) sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2015, closing a stake of 21,891 shares — an estimated $3.42M sold.

Highland Capital Management (Texas) first reported a position in ICPT in Q2 2013 and held it in 7 quarters. The position peaked at $4.2M in Q3 2014. 200 funds tracked by Wall St. Rank hold ICPT as of Q1 2015.

Highland Capital Management (Texas) reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
Highland Capital Management (Texas) sold 21,891 Intercept Pharmaceuticals, Inc. shares in Q1 2015, an estimated $3.42M.
Highland Capital Management (Texas) first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and held it in 7 quarters.
Highland Capital Management (Texas)'s Intercept Pharmaceuticals, Inc. position peaked at $4.2M in Q3 2014.
200 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2015.

Based on Highland Capital Management (Texas)'s 13F filing for Q1 2015, filed 15 May 2015.